// COMPANY
Apnimed
SECTOR HEALTHTECHMENTIONS 1LAST SEEN JULY 31, 2026
// OVERVIEW
Cambridge, MA-based developer of a pill for obstructive sleep apnea
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·Axios Pro Rata·JULY 31, 2026
“Raised $192m in its IPO. It priced 12m shares at $16, versus plans to offer 10m shares at $14-$16.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.